-+ 0.00%
-+ 0.00%
-+ 0.00%

Cansino (688185.SH): The company is developing mRNA preventive vaccines and therapeutic biological products

Zhitongcaijing·08/21/2026 14:25:14
Listen to the news

Zhitong Finance App News, Cansino (688185.SH) issued a stock price change announcement stating that the company is concerned about the recent development of mRNA technology in the market. The mRNA platform is one of the technology platforms in the company's layout. The company is developing mRNA preventive vaccines and therapeutic biological products, as well as related delivery systems. In the field of treatment, the company is promoting research and development of mRNA vaccines for the treatment of indications such as glioblastoma, rhabdomyosarcoma, and cervical cancer, as well as in vivo CAR related therapies, which are currently in the early stages.